William Blair initiated coverage on Contineum Therapeutics
$CTNM
Biotechnology: Pharmaceutical Preparations
Health Care
William Blair initiated coverage of Contineum Therapeutics with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/20/2025 | Outperform | William Blair | |
| 10/22/2024 | $32.00 | Outperform | Robert W. Baird |